| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914511 | Molecular Oncology | 2016 | 16 Pages |
Abstract
Mel-flufen alone or in combination with cisplatin, gemcitabine or Src inhibition holds promise as a novel treatment for UC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kristina Viktorsson, Carl-Henrik Shah, Therese Juntti, Petra Hååg, Katarzyna Zielinska-Chomej, Adam Sierakowiak, Karin Holmsten, Jessica Tu, Jack Spira, Lena Kanter, Rolf Lewensohn, Anders Ullén,